TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2008

Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantation.

Mehdi Hamadani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.